Cell therapy of a patient with type III <i>osteogenesis imperfecta</i> caused by mutation in <i>COL1A2</i> gene and unstable collagen type I

Journals Menu

Follow SCIRP

ISSN Print: 2162-4453
ISSN Online: 2162-4461
www.scirp.org/journal/ojgen
E-mail: ojgen@scirp.org

Citations h5-index & Ranking*

"Cell therapy of a patient with type III osteogenesis imperfecta caused by mutation in COL1A2 gene and unstable collagen type I"
written by Marcin Majka, Magdalena Janeczko, Jolanta Goździk, Danuta Jarocha, Aleksandra Auguściak-Duma, Joanna Witecka, Marta Lesiak, Halina Koryciak-Komarska, Aleksander L. Sieroń, Jacek Józef Pietrzyk,
published by Open Journal of Genetics, Vol.3 No.1, 2013

has been cited by the following article(s):

[1]	Curative cell and gene therapy for osteogenesis imperfecta
	Journal of Bone and …, 2022

[2]	Osteogenesis imperfecta: current and prospective therapies
	Kujawa, M Uroczynska, KL Stepien… - Biomolecules, 2021

[3]	Mutations in COL1A1 and COL1A2 Genes Associated with Osteogenesis Imperfecta (OI) Types I or III.
	2018

[4]	САВЕЛИЕВА НАТАЛИА

[1]	Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets Pharmaceuticals, 2023 DOI:10.3390/ph16101414

[2]	Curative Cell and Gene Therapy for Osteogenesis Imperfecta Journal of Bone and Mineral Research, 2022 DOI:10.1002/jbmr.4549

[3]	Osteogenesis Imperfecta: Current and Prospective Therapies Biomolecules, 2021 DOI:10.3390/biom11101493

[4]	Curative Cell and Gene Therapy for Osteogenesis Imperfecta Journal of Bone and Mineral Research, 2020 DOI:10.1002/jbmr.4549

Follow SCIRP